medRxiv
NMR metabolomics improves prediction of cardiometabolic diseases
In 54,933 healthcare system participants, profiling 250 NMR biomarkers enhanced standard risk prediction for type 2 diabetes, kidney disease, and liver disease.In 54,933 healthcare system participants, profiling 250 NMR biomarkers enhanced standard risk prediction for type 2 diabetes, kidney disease, and liver disease.
Preprint: cohort study of 54,933 peopleBiomarkers